A 2020 study published in Viruses (MDPI), titled “Growing Trend of Fighting Infections in Aquaculture Environment – Opportunities and Challenges of Phage Therapy”, provides a

A team of scientists from Proteon Pharmaceuticals, the Biobank Lodz, and the University of Agriculture in Cracow has developed an innovative method for identifying strains

We are excited to announce that our bacteriophage-based technology has been granted patent protection by the Polish Patent Office. The invention, “Bacteriophage strains and their

Our research, published in 2020 in Viruses (MDPI), titled ‘Comprehensive Evaluation of the Safety and Efficacy of BAFASAL® Bacteriophage Preparation for the Reduction of Salmonella

Temos o prazer de partilhar o progresso significativo que a Proteon Pharmaceuticals fez em 2024. A nossa empresa reforçou a sua posição no mercado, avançou com as suas iniciativas de investigação e expandiu

A Proteon Pharmaceuticals tem o prazer de anunciar que o Ministério da Agricultura, Pecuária e Abastecimento (MAPA) do Brasil registou o BAFASAL PRO, o nosso mais recente medicamento à base de bacteriófagos